Pharmaceutical manufacturing

Pfizer signs are seen out front of the Pfizer Research & Development Laboratories Wednesday, July 22, 2020, in Groton, Conn. Pfizer on Tuesday, July 28, reported a 32% plunge in second-quarter profit, as the global coronavirus pandemic limited marketing of and new prescriptions for its medicines. Still, the biggest U.S. drugmaker posted a solid profit and nudged up parts of its 2020 financial forecast. (AP Photo/Stew Milne)
October 27, 2020 - 6:49 am
Drugmaker Pfizer saw its third-quarter profit plunge 71%, mainly due to an $8.1 billion gain a year earlier from selling its consumer health care business to a GlaxoSmithKline joint venture, but managed to top Wall Street expectations. Meanwhile, the New York-based company on Tuesday said...
Read More
FILE - In this Wednesday, June 24, 2020 file photo, a volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa's first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. On Friday, Oct. 23, 2020, AstraZeneca Inc. announced that the Food and Drug Administration is letting it resume testing of its COVID-19 vaccine candidate in the U.S. (Siphiwe Sibeko/Pool via AP)
October 23, 2020 - 5:30 pm
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates. Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study...
Read More
FILE - In this July 27, 2020, file photo, Nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. The U.S. Food and Drug Administration will hold a meeting to discuss the process of approving COVID-19 vaccines. (AP Photo/Hans Pennink, File)
October 22, 2020 - 7:26 pm
WASHINGTON (AP) — Scientific advisers told U.S. regulators Thursday they’re concerned that allowing emergency use of a COVID-19 vaccine could damage confidence in the shots and make it harder to ever find out how well they really work. The Food and Drug Administration may have to decide by year's...
Read More
Brazil's President Jair Bolsonaro listens during a presentation at the Planalto Presidential Palace in Brasilia, Brazil, Monday, Oct. 19, 2020. The Brazilian government announced the results of clinical tests with use of the drug Nitazoxanide for COVID-19 treatment. (AP Photo/Eraldo Peres)
October 21, 2020 - 1:32 pm
SAO PAULO (AP) — Brazil's President Jair Bolsonaro rejected on Wednesday the announced purchase of 46 million doses of a potential vaccine against COVID-19 being developed by a Chinese company and tested in the state governed by his political rival, prompting concern he was allowing politics to...
Read More
A worker moves boxes at Snowman Logistics, India's largest cold storage company in Taloja, on the outskirts of Mumbai, India, Saturday, Oct. 17, 2020. The vaccine cold chain hurdle is just the latest disparity of the pandemic weighted against the poor, who more often live and work in crowded conditions that allow the virus to spread, have little access to medical oxygen vital to COVID-19 treatment, and whose health systems lack labs, supplies or technicians to carry out large-scale testing. (AP Photo/Rajanish Kakade)
October 19, 2020 - 2:23 am
GAMPELA, Burkina Faso (AP) — The chain breaks here, in a tiny medical clinic in Burkina Faso that went nearly a year without a working refrigerator. From factory to syringe, the world’s most promising coronavirus vaccine candidates need non-stop sterile refrigeration to stay potent and safe. But...
Read More
FILE - In this July 17, 2020 file photo, a senior citizen holds the hand of a care coordinator at a Health facility in Miami. Federal health officials on Friday unveiled a plan to get approved coronavirus vaccines to nursing home residents free of cost, with the aid of two national pharmacy chains. No vaccine has yet been approved by the Food and Drug Administration, and the distribution program is contingent on that happening first. (AP Photo/Wilfredo Lee)
October 16, 2020 - 1:43 pm
WASHINGTON (AP) — Federal health officials on Friday unveiled a plan to get yet-to-be-approved coronavirus vaccines to nursing home residents free of charge, enlisting two national pharmacy chains to help. Such a vaccine is not yet available, and that led to skepticism from some long-term care...
Read More
FILE - In this Feb. 26, 2019 file photo, Albert Bourla, chief executive officer of Pfizer, prepares to testify before the Senate Finance Committee hearing on drug prices, on Capitol Hill in Washington. Pfizer Inc.'s CEO says it can't seek emergency authorization of its COVID-19 vaccine before the third week of November — and that's if everything goes well. The announcement on Friday, Oct. 16, 2020, by Bourla reflects estimates from leading scientists that its unlikely data would start to emerge until November or December showing any of the leading vaccine candidates work. (AP Photo/Pablo Martinez Monsivais, File)
October 16, 2020 - 9:09 am
NEW YORK (AP) — Pfizer Inc. cannot request emergency authorization of its COVID-19 vaccine before the third week of November -- and that’s if everything goes well, the company’s CEO announced Friday. Despite President Donald Trump’s repeated promises of a vaccine before Election Day, scientists...
Read More
In this Sept. 24, 2020, file photo, an employee manually inspects syringes of the SARS CoV-2 Vaccine for COVID-19 produced by Sinovac at its factory in Beijing. China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general public and a biotech company providing another free to students going abroad. (AP Photo/Ng Han Guan, File)
October 16, 2020 - 5:50 am
TAIPEI, Taiwan (AP) — China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general public and a biotech company providing another free to students going abroad. The city of Jiaxing, south of Shanghai, is offering a vaccine...
Read More
FILE - In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. On top of rigorous final testing in tens of thousands of people, any COVID-19 vaccines cleared for widespread use will get additional safety evaluation as they're rolled out. (University of Maryland School of Medicine via AP)
October 14, 2020 - 10:09 am
Facing public skepticism about rushed COVID-19 vaccines, U.S. health officials are planning extra scrutiny of the first people vaccinated when shots become available — an added safety layer experts call vital. A new poll suggests those vaccine fears are growing. With this week's pause of a second...
Read More
FILE - In this Oct. 9, 2020, file photo, a health worker, right, administers the first dose of a COVID-19 vaccine currently on phase III clinical trials to Cem Gun, an emergency medicine physician at the Acibadem Hospital in Istanbul. The World Bank has approved $12 billion in financing to help developing countries buy and distribute coronavirus vaccines, tests, and treatments, aiming to support the vaccination of up to 1 billion people, the bank said in a statement late Tuesday, Oct. 13. (AP Photo/Emrah Gurel, File)
October 14, 2020 - 3:22 am
The World Bank has approved $12 billion in financing to help developing countries buy and distribute coronavirus vaccines, tests, and treatments, aiming to support the vaccination of up to 1 billion people. The $12 billion “envelope" is part of a wider World Bank Group package of up to $160 billion...
Read More

Pages